• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Publisher Correction: Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia.

作者信息

Haffner Dieter, Emma Francesco, Seefried Lothar, Högler Wolfgang, Javaid Kassim M, Bockenhauer Detlef, Bacchetta Justine, Eastwood Deborah, Biosse Duplan Martin, Schnabel Dirk, Wicart Philippe, Ariceta Gema, Levtchenko Elena, Harvengt Pol, Kirchhoff Martha, Gardiner Oliver, Di Rocco Federico, Chaussain Catherine, Brandi Maria Luisa, Savendahl Lars, Briot Karine, Kamenický Peter, Rejnmark Lars, Linglart Agnès

机构信息

Department of Paediatric Kidney, Liver, Metabolic and Neurological Diseases, Hannover Medical, School, Hannover, Germany.

Center for Congenital Kidney Diseases, Center for Rare Diseases, Hannover Medical School, Hannover, Germany.

出版信息

Nat Rev Nephrol. 2025 May;21(5):355. doi: 10.1038/s41581-025-00939-0.

DOI:10.1038/s41581-025-00939-0
PMID:39905262
Abstract
摘要

相似文献

1
Publisher Correction: Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia.出版商更正：X连锁低磷血症诊断与管理的临床实践建议。
Nat Rev Nephrol. 2025 May;21(5):355. doi: 10.1038/s41581-025-00939-0.
2
X-Linked Hypophosphataemia and Burosumab: A Systemic Disease With a New Treatment.X连锁低磷血症与布罗索尤单抗：一种采用新疗法的全身性疾病。
J Paediatr Child Health. 2025 May;61(5):685-700. doi: 10.1111/jpc.70015. Epub 2025 Feb 26.
3
Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia.X连锁低磷血症诊断与管理的临床实践建议
Nat Rev Nephrol. 2025 May;21(5):330-354. doi: 10.1038/s41581-024-00926-x. Epub 2025 Jan 15.
4
Efficacy and safety of burosumab in children aged 1-4 years with X-linked hypophosphataemia: a multicentre, open-label, phase 2 trial.布罗索尤单抗治疗 1-4 岁 X 连锁低磷血症儿童的疗效和安全性：一项多中心、开放标签、2 期临床试验。
Lancet Diabetes Endocrinol. 2019 Mar;7(3):189-199. doi: 10.1016/S2213-8587(18)30338-3. Epub 2019 Jan 9.
5
Approach to hypophosphataemia in intensive care units - a nationwide survey.重症监护病房低磷血症的处理——一项全国性调查。
Neth J Med. 2012 Nov;70(9):425-30.
6
Burosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trial.布罗索尤单抗治疗 X 连锁低磷血症儿童：一项随机、活性药物对照、开放标签、3 期临床试验。
Lancet. 2019 Jun 15;393(10189):2416-2427. doi: 10.1016/S0140-6736(19)30654-3. Epub 2019 May 16.
7
Hungry bone syndrome and normalisation of renal phosphorus threshold after total parathyroidectomy for tertiary hyperparathyroidism in X-linked hypophosphataemia: a case report.X连锁低磷血症性三发性甲状旁腺功能亢进症患者行甲状旁腺全切术后的饥饿骨综合征及肾磷阈值正常化：一例报告
J Med Case Rep. 2014 Mar 4;8:84. doi: 10.1186/1752-1947-8-84.
8
Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia.X 连锁低磷血症的诊断和管理临床实践建议。
Nat Rev Nephrol. 2019 Jul;15(7):435-455. doi: 10.1038/s41581-019-0152-5.
9
Hypophosphataemia. Pathophysiology, effects and management on the intensive care unit.
Anaesthesia. 1998 Sep;53(9):895-902. doi: 10.1046/j.1365-2044.1998.00463.x.
10
Hypophosphataemia risk associated with ferric carboxymaltose in heart failure: A pooled analysis of clinical trials.铁羧基麦芽糖复合物相关的心力衰竭低磷血症风险：临床试验的汇总分析。
ESC Heart Fail. 2023 Apr;10(2):1294-1304. doi: 10.1002/ehf2.14286. Epub 2023 Feb 1.

引用本文的文献

1
XLH Matters 2024: expert insights and practical tools for enhancing care of people living with X-linked hypophosphataemia.2024年XLH问题：改善X连锁低磷血症患者护理的专家见解与实用工具
Orphanet J Rare Dis. 2025 Sep 18;20(Suppl 2):477. doi: 10.1186/s13023-025-03930-x.
2
The Diagnosis and Therapy of XLH.XLH的诊断与治疗。
Calcif Tissue Int. 2025 Apr 28;116(1):66. doi: 10.1007/s00223-025-01374-w.